TranS1, which develops and designs devices for degenerative lower lumber spine conditions, admits no wrongdoing as part of the settlement, according to the report.
The settlement should be finalized within the next few months.
More Articles on Devices:
Life Spine Releases Lateral Retractor, Spacer Devices
NUI Galway Plans Release of OsteoAnchor Joint Technology
Drug-Device Combination Market to Reach $30.5B by 2017
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.